Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Equine adipose-derived stem cells modulate in vitro neutrophil extracellular trap release by polymorphonuclear neutrophils.

Salinas-Varas C., Espinosa G., Muñoz-Caro T., Conejeros I., Gärtner U., Fey K.

Laboratory Study on Chronic Inflammation, Immune Modulation, published in Front Vet Sci (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Front Vet Sci (2025)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
41200546
PMCID
PMC12586003
DOI
10.3389/fvets.2025.1685757

Abstract (original English)

Neutrophil extracellular trap (NET) are thin and long web-like structures composed of DNA and antimicrobial proteins released by activated polymorphonuclear neutrophils (PMN) as part of the innate immune response. Adipose-derived stem cells (ADSCs) represent an accessible, abundant and minimal invasive source of mesenchymal stem cells (MSCs), with high regenerative potential, immunomodulatory and anti-inflammatory properties. Although recognized immunomodulatory properties of ADSCs, their interaction with PMN and their role on NET formation remains poorly characterized. The present study aimed to evaluate the in vitro effects of equine ADSCs on NET formation by equine PMN. Equine ADSCs were isolated from two different sources of adipose tissue, subcutaneous and retroperitoneal adipose stores. Equine PMN were isolated from peripheral blood with a discontinuous density gradient and stimulated with phorbol 12-myristate 13-acetate (PMA) to induce NET release as positive control. Scanning electron microscopy (SEM) and immunofluorescence microscopy (IFM) analyses were performed to assess NET release by equine PMN co-cultured with ADSCs. In vitro IFM-NET quantification revealed a significant NET decrease for PMN co-cultured with ADSCs and PMA. Furthermore, extracellular DNA quantification showed that inhibition of equine NET is dependent on the ADSCs to PMN ratio, for PMA and ionomyci

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research